All articles by Sarah Houlton – Page 10
-
Feature
Drugs for a developing world
Diseases affecting the developing world have long been neglected, but new partnerships between governments, charities and pharmaceutical firms could change that, says Sarah Houlton
-
News
Indian court dismisses Bayer's patent law case
Bayer has failed in its attempt to stop Indian regulators approving a copy-cat version of one of its patented drugs
-
News
Testing times: prediction of hepatitis C response
A new genetic test could predict which patients will benefit from treatment, and which will suffer side effects
-
News
ERC not up to scratch
Two-year review highlights fundamental operational problems within the European Research Council
-
Careers
Profile: Life, but not as we know it
In Second Life real people live in a virtual world. Joanna Scott has a actual job there, organising scientific events within the online environment, reports Sarah Houlton
-
Careers
Company Profile: Chemicals to order
Excelsyn, which specialises in the gram to kilo scale manufacture of fine chemicals, is profiting from the growing market for niche products, reports Sarah Houlton
-
News
Branded drugs' competition-free days numbered
EU and US authorities look to clamp down on pharma's deals to delay generic drugs
-
News
New department takes responsibility for UK science
Science and business reunite as DIUS scrapped in UK government department reshuffle
-
News
Agrochemical firms in patent battle
Agrochemical giants are locking horns over biotech patents for genetic technologies
-
FeatureNanopores for thought
Sarah Houlton talks to Hagan Bayley, the 2008 Chemistry World Entrepreneur of the year
-
Careers
Profile: Commercial catalysts
Ian Archer has his dream career as a process chemist. As head of process chemistry at Ingenza, he is now getting involved in technology transfer, as he tells Sarah Houlton
-
News
Lead-lined clouds
Lead in the atmosphere causes clouds to form at warmer temperatures and with less water
-
News
Double standard in pesticide ban?
EU review approves pesticides used in organic farming based on incomplete data, sparking claims of double standards
-
News
Integrin inhibitors could promote tumour growth
Integrin inhibitors are being investigated to treat cancer, but new research suggests they could actually promote tumour growth
-
News
Mega mergers sweep pharma industry
The list of mergers and acquisitions in the pharma continues to grow, with four major deals in recent weeks
-
Careers
Who's who: Colourful chemistry
Sarah Houlton marvels at the rainbow of career options available to colour chemists
-
Careers
Profile: Tomorrow's careers
A wealth of skills took Kate Bellingham from a first degree in physics, to careers as a computer programmer, TV presenter, maths teacher, and finally a national champion for careers in science, technology, engineering and maths (Stem), writes Sarah Houlto
-
Careers
Profile: The science business
US materials scientist Brian Smith got himself an MBA in order to build a business based on his research
-
Feature
Cells with potential
Beyond the medical breakthroughs, the hype and the controversy, how are the big drug companies developing their use of stem cells? Sarah Houlton reports